DMXL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.583600E-01
Normal-vs-Stage2
2.913200E-01
Normal-vs-Stage3
2.694200E-01
Normal-vs-Stage4
1.819420E-01
Stage1-vs-Stage2
4.229200E-01
Stage1-vs-Stage3
3.656200E-01
Stage1-vs-Stage4
7.396800E-01
Stage2-vs-Stage3
2.650600E-01
Stage2-vs-Stage4
8.425200E-01
Stage3-vs-Stage4
5.469400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.993000E-01
Normal-vs-AfricanAmerican
2.050800E-01
Normal-vs-Asian
2.626000E-01
Caucasian-vs-AfricanAmerican
4.588000E-01
Caucasian-vs-Asian
3.476600E-01
AfricanAmerican-vs-Asian
3.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.886400E-01
Normal-vs-Female
3.153600E-01
Male-vs-Female
2.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.774200E-01
Normal-vs-Age(41-60Yrs)
3.590800E-01
Normal-vs-Age(61-80Yrs)
2.762400E-01
Normal-vs-Age(81-100Yrs)
2.775200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.004800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.481800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.231400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.003200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.129160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.727800E-01
Normal-vs-Daily Drinker
2.595400E-01
Normal-vs-Weekly Drinker
2.459400E-01
Normal-vs-Occasional Drinker
3.555800E-01
Normal-vs-Social Drinker
3.104600E-01
Non Drinker-vs-Daily Drinker
6.564800E-01
Non Drinker-vs-Weekly Drinker
3.969400E-01
Non Drinker-vs-Occasional Drinker
1.531620E-01
Non Drinker-vs-Social Drinker
4.430800E-01
Daily Drinker-vs-Weekly Drinker
7.198800E-01
Daily Drinker-vs-Occasional Drinker
9.783500E-02
Daily Drinker-vs-Social Drinker
3.412600E-01
Weekly Drinker-vs-Occasional Drinker
7.900400E-02
Weekly Drinker-vs-Social Drinker
2.403800E-01
Occasional Drinker-vs-Social Drinker
5.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.962400E-02
Normal-vs-Grade 2
2.520700E-03
Normal-vs-Grade 3
1.279990E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.168600E-01
Grade 1-vs-Grade 3
2.315400E-01
Grade 1-vs-Grade 4
6.962400E-02
Grade 2-vs-Grade 3
9.434000E-01
Grade 2-vs-Grade 4
2.520700E-03
Grade 3-vs-Grade 4
1.279990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.701000E-01
Normal-vs-NonDiabetic
2.903000E-01
Diabetic-vs-NonDiabetic
4.131200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.230000E-01
Normal-vs-NoPancreatitis
2.908200E-01
Pancreatitis-vs-NoPancreatitis
3.221900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.224600E-01
Normal-vs-N1
2.895400E-01
N0-vs-N1
3.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.425000E-01
Normal-vs-TP53-NonMutant
3.241600E-01
TP53-Mutant-vs-TP53-NonMutant
1.627810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
